Interleukin-6 as a potential biomarker of COVID-19 progression
Gespeichert in:
| Veröffentlicht in: | Médecine et maladies infectieuses 2020-06, Vol.50 (4), p.382-383 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 383 |
|---|---|
| container_issue | 4 |
| container_start_page | 382 |
| container_title | Médecine et maladies infectieuses |
| container_volume | 50 |
| creator | Ulhaq, Zulvikar Syambani Soraya, Gita Vita |
| description | |
| doi_str_mv | 10.1016/j.medmal.2020.04.002 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7129451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0399077X20300883</els_id><sourcerecordid>2453789369</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-20c8a79a2b9b01f0559d3ad1d070791fea4ed85da49aae282d06bff62e01412d3</originalsourceid><addsrcrecordid>eNp9kU9v1DAQxS1ERbeFb4BQJC5cEmYcx44vldBCYaVKvbSIm-XEk-JtNl7spBLfHldbyp9DTz7Mb57fm8fYa4QKAeX7bbUjt7NjxYFDBaIC4M_YCpXUpZQanrMV1FqXoNS3Y3aS0jYDHBBesOOa80Y3ElbsbDPNFEdabv1UysKmwhb7MNM0ezsWnQ87G28pFmEo1pdfNx9L1MU-hptIKfkwvWRHgx0TvXp4T9n1-aer9Zfy4vLzZv3houyFxrnk0LdWacs73QEO0DTa1dahAwVK40BWkGsbZ4W2lnjLHchuGCQnQIHc1afs7KC7X7ocu8_-oh3NPvrs76cJ1pt_J5P_bm7CnVHItWgwC7x7EIjhx0JpNjufehpHO1FYkuF1q6REVCqjb_9Dt2GJU45nuGhq1epa6kyJA9XHkFKk4dEMgrkvyGzNoSBzX5ABYfL989qbv4M8Lv1u5E9Syue88xRN6j1NPTkfqZ-NC_7pH34B3cCiig</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2453789369</pqid></control><display><type>article</type><title>Interleukin-6 as a potential biomarker of COVID-19 progression</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ulhaq, Zulvikar Syambani ; Soraya, Gita Vita</creator><creatorcontrib>Ulhaq, Zulvikar Syambani ; Soraya, Gita Vita</creatorcontrib><identifier>ISSN: 0399-077X</identifier><identifier>EISSN: 1769-6690</identifier><identifier>DOI: 10.1016/j.medmal.2020.04.002</identifier><identifier>PMID: 32259560</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Betacoronavirus - isolation & purification ; Biomarker ; Biomarkers ; Biomarkers - blood ; Coronavirus Infections - blood ; Coronavirus Infections - diagnosis ; Coronavirus Infections - pathology ; COVID-19 ; Humans ; IL-6 ; Interleukin 6 ; Interleukin-6 - blood ; Pandemics ; Pneumonia, Viral - blood ; Pneumonia, Viral - diagnosis ; Pneumonia, Viral - pathology ; SARS-CoV-2 ; Severity of Illness Index</subject><ispartof>Médecine et maladies infectieuses, 2020-06, Vol.50 (4), p.382-383</ispartof><rights>2020 Elsevier Masson SAS</rights><rights>Copyright Elsevier Science Ltd. Jun 2020</rights><rights>2020 Elsevier Masson SAS. All rights reserved. 2020 Elsevier Masson SAS</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-20c8a79a2b9b01f0559d3ad1d070791fea4ed85da49aae282d06bff62e01412d3</citedby><cites>FETCH-LOGICAL-c491t-20c8a79a2b9b01f0559d3ad1d070791fea4ed85da49aae282d06bff62e01412d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0399077X20300883$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32259560$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ulhaq, Zulvikar Syambani</creatorcontrib><creatorcontrib>Soraya, Gita Vita</creatorcontrib><title>Interleukin-6 as a potential biomarker of COVID-19 progression</title><title>Médecine et maladies infectieuses</title><addtitle>Med Mal Infect</addtitle><subject>Betacoronavirus - isolation & purification</subject><subject>Biomarker</subject><subject>Biomarkers</subject><subject>Biomarkers - blood</subject><subject>Coronavirus Infections - blood</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - pathology</subject><subject>COVID-19</subject><subject>Humans</subject><subject>IL-6</subject><subject>Interleukin 6</subject><subject>Interleukin-6 - blood</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - blood</subject><subject>Pneumonia, Viral - diagnosis</subject><subject>Pneumonia, Viral - pathology</subject><subject>SARS-CoV-2</subject><subject>Severity of Illness Index</subject><issn>0399-077X</issn><issn>1769-6690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9v1DAQxS1ERbeFb4BQJC5cEmYcx44vldBCYaVKvbSIm-XEk-JtNl7spBLfHldbyp9DTz7Mb57fm8fYa4QKAeX7bbUjt7NjxYFDBaIC4M_YCpXUpZQanrMV1FqXoNS3Y3aS0jYDHBBesOOa80Y3ElbsbDPNFEdabv1UysKmwhb7MNM0ezsWnQ87G28pFmEo1pdfNx9L1MU-hptIKfkwvWRHgx0TvXp4T9n1-aer9Zfy4vLzZv3houyFxrnk0LdWacs73QEO0DTa1dahAwVK40BWkGsbZ4W2lnjLHchuGCQnQIHc1afs7KC7X7ocu8_-oh3NPvrs76cJ1pt_J5P_bm7CnVHItWgwC7x7EIjhx0JpNjufehpHO1FYkuF1q6REVCqjb_9Dt2GJU45nuGhq1epa6kyJA9XHkFKk4dEMgrkvyGzNoSBzX5ABYfL989qbv4M8Lv1u5E9Syue88xRN6j1NPTkfqZ-NC_7pH34B3cCiig</recordid><startdate>20200601</startdate><enddate>20200601</enddate><creator>Ulhaq, Zulvikar Syambani</creator><creator>Soraya, Gita Vita</creator><general>Elsevier Masson SAS</general><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T5</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200601</creationdate><title>Interleukin-6 as a potential biomarker of COVID-19 progression</title><author>Ulhaq, Zulvikar Syambani ; Soraya, Gita Vita</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-20c8a79a2b9b01f0559d3ad1d070791fea4ed85da49aae282d06bff62e01412d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Betacoronavirus - isolation & purification</topic><topic>Biomarker</topic><topic>Biomarkers</topic><topic>Biomarkers - blood</topic><topic>Coronavirus Infections - blood</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - pathology</topic><topic>COVID-19</topic><topic>Humans</topic><topic>IL-6</topic><topic>Interleukin 6</topic><topic>Interleukin-6 - blood</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - blood</topic><topic>Pneumonia, Viral - diagnosis</topic><topic>Pneumonia, Viral - pathology</topic><topic>SARS-CoV-2</topic><topic>Severity of Illness Index</topic><toplevel>online_resources</toplevel><creatorcontrib>Ulhaq, Zulvikar Syambani</creatorcontrib><creatorcontrib>Soraya, Gita Vita</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Médecine et maladies infectieuses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ulhaq, Zulvikar Syambani</au><au>Soraya, Gita Vita</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-6 as a potential biomarker of COVID-19 progression</atitle><jtitle>Médecine et maladies infectieuses</jtitle><addtitle>Med Mal Infect</addtitle><date>2020-06-01</date><risdate>2020</risdate><volume>50</volume><issue>4</issue><spage>382</spage><epage>383</epage><pages>382-383</pages><issn>0399-077X</issn><eissn>1769-6690</eissn><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>32259560</pmid><doi>10.1016/j.medmal.2020.04.002</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0399-077X |
| ispartof | Médecine et maladies infectieuses, 2020-06, Vol.50 (4), p.382-383 |
| issn | 0399-077X 1769-6690 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7129451 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Betacoronavirus - isolation & purification Biomarker Biomarkers Biomarkers - blood Coronavirus Infections - blood Coronavirus Infections - diagnosis Coronavirus Infections - pathology COVID-19 Humans IL-6 Interleukin 6 Interleukin-6 - blood Pandemics Pneumonia, Viral - blood Pneumonia, Viral - diagnosis Pneumonia, Viral - pathology SARS-CoV-2 Severity of Illness Index |
| title | Interleukin-6 as a potential biomarker of COVID-19 progression |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T06%3A08%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-6%20as%20a%20potential%20biomarker%20of%20COVID-19%20progression&rft.jtitle=Me%CC%81decine%20et%20maladies%20infectieuses&rft.au=Ulhaq,%20Zulvikar%20Syambani&rft.date=2020-06-01&rft.volume=50&rft.issue=4&rft.spage=382&rft.epage=383&rft.pages=382-383&rft.issn=0399-077X&rft.eissn=1769-6690&rft_id=info:doi/10.1016/j.medmal.2020.04.002&rft_dat=%3Cproquest_pubme%3E2453789369%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2453789369&rft_id=info:pmid/32259560&rft_els_id=S0399077X20300883&rfr_iscdi=true |